tiprankstipranks
Trending News
More News >
Rainbow Childrens Medicare Limited (IN:RAINBOW)
:RAINBOW
India Market
Advertisement

Rainbow Childrens Medicare Limited (RAINBOW) Stock Forecast & Price Target

Compare
0 Followers
See the Price Targets and Ratings of:

RAINBOW Financial Forecast

RAINBOW Earnings Forecast

Next quarter’s earnings estimate for RAINBOW is ₹4.88 with a range of ₹4.10 to ₹5.90. The previous quarter’s EPS was ₹5.55. RAINBOW beat its EPS estimate 75.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 42.22% of the time in the same period. In the last calendar year RAINBOW has Outperformed its overall industry.
Next quarter’s earnings estimate for RAINBOW is ₹4.88 with a range of ₹4.10 to ₹5.90. The previous quarter’s EPS was ₹5.55. RAINBOW beat its EPS estimate 75.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 42.22% of the time in the same period. In the last calendar year RAINBOW has Outperformed its overall industry.

RAINBOW Sales Forecast

Next quarter’s sales forecast for RAINBOW is ₹3.55B with a range of ₹3.46B to ₹3.67B. The previous quarter’s sales results were ₹3.70B. RAINBOW beat its sales estimates 50.00% of the time in past 12 months, while its overall industry beat sales estimates 56.06% of the time in the same period. In the last calendar year RAINBOW has Outperformed its overall industry.
Next quarter’s sales forecast for RAINBOW is ₹3.55B with a range of ₹3.46B to ₹3.67B. The previous quarter’s sales results were ₹3.70B. RAINBOW beat its sales estimates 50.00% of the time in past 12 months, while its overall industry beat sales estimates 56.06% of the time in the same period. In the last calendar year RAINBOW has Outperformed its overall industry.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on IN:RAINBOW
TipRanks AITipRanks
Not Ranked
TipRanks
₹1,753
Buy
29.62%
Upside
07/08/25
Rainbow Childrens Medicare Limited's overall stock score is primarily supported by strong financial performance, characterized by revenue growth and cash flow generation. Technical analysis reflects a positive trend, albeit with potential overvaluation risks as indicated by the high P/E ratio and nearing overbought conditions. The absence of earnings call data and corporate events limits the analysis to these factors.
J.P. Morgan Analyst forecast on IN:RAINBOW
Bansi DesaiJ.P. Morgan
J.P. Morgan
₹1,680₹1,770
Buy
30.88%
Upside
Reiterated
02/11/25
Rainbow Children#xE2;#x80;#x99;s Hospitals (RAINBOW:IN) PT Raised to INR1,770 at JPMorganJPMorgan analyst Bansi Desai raised the price target on Rainbow Children’s Hospitals (RAINBOW:IN) to INR1,770.00 (from INR1,680.00) while maintaining a Overweight rating.
HSBC
₹1,800₹1,720
Buy
27.18%
Upside
Reiterated
02/11/25
Rainbow Children#xE2;#x80;#x99;s Hospitals (RAINBOW:IN) PT Lowered to INR1,720 at HSBCHSBC analyst Damayanti Kerai lowered the price target on Rainbow Children’s Hospitals (RAINBOW:IN) to INR1,720.00 (from INR1,800.00) while maintaining a Buy rating.
Centrum Broking Analyst forecast on IN:RAINBOW
Sumit GuptaCentrum Broking
Not Ranked
Centrum Broking
₹1,610
Hold
19.05%
Upside
Reiterated
02/10/25
Kotak Mahindra Analyst forecast on IN:RAINBOW
Alankar GarudeKotak Mahindra
Kotak Mahindra
₹1,400
Sell
3.52%
Upside
Reiterated
12/27/24
Kotak Reiterates Reduce (3) Rating on Rainbow Children#xE2;#x80;#x99;s Hospitals (RAINBOW:IN)Kotak analyst Alankar Garude reiterated a Reduce (3) rating and INR1,400.00 price target on Rainbow Children’s Hospitals (RAINBOW:IN).
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on IN:RAINBOW
TipRanks AITipRanks
Not Ranked
TipRanks
₹1,753
Buy
29.62%
Upside
07/08/25
Rainbow Childrens Medicare Limited's overall stock score is primarily supported by strong financial performance, characterized by revenue growth and cash flow generation. Technical analysis reflects a positive trend, albeit with potential overvaluation risks as indicated by the high P/E ratio and nearing overbought conditions. The absence of earnings call data and corporate events limits the analysis to these factors.
J.P. Morgan Analyst forecast on IN:RAINBOW
Bansi DesaiJ.P. Morgan
J.P. Morgan
₹1,680₹1,770
Buy
30.88%
Upside
Reiterated
02/11/25
Rainbow Children#xE2;#x80;#x99;s Hospitals (RAINBOW:IN) PT Raised to INR1,770 at JPMorganJPMorgan analyst Bansi Desai raised the price target on Rainbow Children’s Hospitals (RAINBOW:IN) to INR1,770.00 (from INR1,680.00) while maintaining a Overweight rating.
HSBC
₹1,800₹1,720
Buy
27.18%
Upside
Reiterated
02/11/25
Rainbow Children#xE2;#x80;#x99;s Hospitals (RAINBOW:IN) PT Lowered to INR1,720 at HSBCHSBC analyst Damayanti Kerai lowered the price target on Rainbow Children’s Hospitals (RAINBOW:IN) to INR1,720.00 (from INR1,800.00) while maintaining a Buy rating.
Centrum Broking Analyst forecast on IN:RAINBOW
Sumit GuptaCentrum Broking
Not Ranked
Centrum Broking
₹1,610
Hold
19.05%
Upside
Reiterated
02/10/25
Kotak Mahindra Analyst forecast on IN:RAINBOW
Alankar GarudeKotak Mahindra
Kotak Mahindra
₹1,400
Sell
3.52%
Upside
Reiterated
12/27/24
Kotak Reiterates Reduce (3) Rating on Rainbow Children#xE2;#x80;#x99;s Hospitals (RAINBOW:IN)Kotak analyst Alankar Garude reiterated a Reduce (3) rating and INR1,400.00 price target on Rainbow Children’s Hospitals (RAINBOW:IN).
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Rainbow Childrens Medicare Limited

1 Month
xxx
Success Rate
1/2 ratings generated profit
50%
Average Return
+1.85%
reiterated a xxx
rating 2 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 50.00% of your transactions generating a profit, with an average return of +1.85% per trade.
3 Months
xxx
Success Rate
2/2 ratings generated profit
100%
Average Return
+6.50%
reiterated a xxx
rating 2 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +6.50% per trade.
1 Year
Success Rate
2/2 ratings generated profit
100%
Average Return
+14.10%
reiterated a buy rating 2 days ago
Copying Damayanti Kerai's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +14.10% per trade.
2 Years
xxx
Success Rate
2/2 ratings generated profit
100%
Average Return
+14.10%
reiterated a xxx
rating 2 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +14.10% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

RAINBOW Analyst Recommendation Trends

Rating
Dec 24
Feb 25
May 25
Jun 25
Strong Buy
0
0
0
0
Buy
0
2
4
5
Hold
0
1
1
1
Sell
1
1
1
0
Strong Sell
0
0
0
0
total
1
4
6
6
In the current month, RAINBOW has received 5 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. RAINBOW average Analyst price target in the past 3 months is 1,625.00.
Each month's total comprises the sum of three months' worth of ratings.

RAINBOW Stock Forecast FAQ

What is IN:RAINBOW’s average 12-month price target, according to analysts?
Based on analyst ratings, Rainbow Childrens Medicare Limited’s 12-month average price target is 1,625.00.
    What is IN:RAINBOW’s upside potential, based on the analysts’ average price target?
    Rainbow Childrens Medicare Limited has 20.16% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Rainbow Childrens Medicare Limited a Buy, Sell or Hold?
          Rainbow Childrens Medicare Limited has a consensus rating of Hold, which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
            What is Rainbow Childrens Medicare Limited’s share price target?
            The average share price target for Rainbow Childrens Medicare Limited is 1,625.00. This is based on 0 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is ₹1,770.00 ,and the lowest forecast is ₹1,400.00. The average share price target represents 20.16% Increase from the current price of ₹1,352.4.
              What do analysts say about Rainbow Childrens Medicare Limited?
              Rainbow Childrens Medicare Limited’s analyst rating consensus is a Hold. This is based on the ratings of 0 Wall Streets Analysts.
                How can I buy shares of Rainbow Childrens Medicare Limited?
                To buy shares of IN:RAINBOW, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis